Japan NT 3 Growth Factor Receptor Market Research Report 2018

March 2018 | 99 pages | ID: J422542281BEN
QYResearch

Abstracts

The global NT 3 Growth Factor Receptor market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Japan plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the NT 3 Growth Factor Receptor development status and future trend in Japan, focuses on top players in Japan, also splits NT 3 Growth Factor Receptor by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

The major players in Japan market include

• Array BioPharma Inc
• AstraZeneca Plc
• Daiichi Sankyo Company Ltd
• Handok Inc
• Ignyta Inc
• Loxo Oncology Inc
• Netris Pharma SAS
• Plexxikon Inc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• AZD-7451
• Larotrectinib
• DS-6051
• LM-22B10
• Others

On the basis of the end users/Application, this report covers

• Breast Cancer
• Brain Cancer
• Solid Tumor
• Colon Cancer
• Fibrosarcoma
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Japan NT 3 Growth Factor Receptor Market Research Report 2018

1 NT 3 GROWTH FACTOR RECEPTOR OVERVIEW

1.1 Product Overview and Scope of NT 3 Growth Factor Receptor
1.2 Classification of NT 3 Growth Factor Receptor by Product Category
  1.2.1 Japan NT 3 Growth Factor Receptor Sales (K Pcs) Comparison by Type (2013-2025)
  1.2.2 Japan NT 3 Growth Factor Receptor Sales (K Pcs) Market Share by Type in 2017
  1.2.3 AZD-7451
  1.2.4 Larotrectinib
  1.2.5 DS-6051
  1.2.6 LM-22B10
  1.2.7 Others
1.3 Japan NT 3 Growth Factor Receptor Market by Application/End Users
  1.3.1 Japan NT 3 Growth Factor Receptor Sales (K Pcs) and Market Share Comparison by Application (2013-2025)
  1.3.2 Breast Cancer
  1.3.3 Brain Cancer
  1.3.4 Solid Tumor
  1.3.5 Colon Cancer
  1.3.6 Fibrosarcoma
  1.3.7 Others
1.4 Japan Revenue and Sales of NT 3 Growth Factor Receptor (2013-2025)
  1.4.1 Japan NT 3 Growth Factor Receptor Sales (K Pcs) and Growth Rate (%)(2013-2025)
  1.4.2 Japan NT 3 Growth Factor Receptor Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 JAPAN NT 3 GROWTH FACTOR RECEPTOR MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Japan NT 3 Growth Factor Receptor Sales (K Pcs) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 Japan NT 3 Growth Factor Receptor Revenue and Share by Players/Manufacturers (2013-2018)
2.3 Japan NT 3 Growth Factor Receptor Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 Japan NT 3 Growth Factor Receptor Market Competitive Situation and Trends
  2.4.1 Japan NT 3 Growth Factor Receptor Market Concentration Rate
  2.4.2 Japan NT 3 Growth Factor Receptor Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in Japan Market
2.5 Japan Players/Manufacturers NT 3 Growth Factor Receptor Manufacturing Base Distribution, Sales Area, Product Type

3 JAPAN NT 3 GROWTH FACTOR RECEPTOR SALES AND REVENUE (VALUE) BY TYPE (2013-2018)

3.1 Japan NT 3 Growth Factor Receptor Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
3.2 Japan NT 3 Growth Factor Receptor Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 Japan NT 3 Growth Factor Receptor Price (USD/Pcs) by Type (2013-2018)
3.4 Japan NT 3 Growth Factor Receptor Sales Growth Rate (%) by Type (2013-2018)

4 JAPAN NT 3 GROWTH FACTOR RECEPTOR SALES BY APPLICATION (2013-2018)

4.1 Japan NT 3 Growth Factor Receptor Sales (K Pcs) and Market Share by Application (2013-2018)
4.2 Japan NT 3 Growth Factor Receptor Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities

5 JAPAN NT 3 GROWTH FACTOR RECEPTOR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

5.1 Array BioPharma Inc
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 NT 3 Growth Factor Receptor Product Category, Application and Specification
    5.1.2.1 Product A
    5.1.2.2 Product B
  5.1.3 Array BioPharma Inc NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.1.4 Main Business/Business Overview
5.2 AstraZeneca Plc
  5.2.1 Company Basic Information, Manufacturing Base and Competitors
  5.2.2 NT 3 Growth Factor Receptor Product Category, Application and Specification
    5.2.2.1 Product A
    5.2.2.2 Product B
  5.2.3 AstraZeneca Plc NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.2.4 Main Business/Business Overview
5.3 Daiichi Sankyo Company Ltd
  5.3.1 Company Basic Information, Manufacturing Base and Competitors
  5.3.2 NT 3 Growth Factor Receptor Product Category, Application and Specification
    5.3.2.1 Product A
    5.3.2.2 Product B
  5.3.3 Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.3.4 Main Business/Business Overview
5.4 Handok Inc
  5.4.1 Company Basic Information, Manufacturing Base and Competitors
  5.4.2 NT 3 Growth Factor Receptor Product Category, Application and Specification
    5.4.2.1 Product A
    5.4.2.2 Product B
  5.4.3 Handok Inc NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.4.4 Main Business/Business Overview
5.5 Ignyta Inc
  5.5.1 Company Basic Information, Manufacturing Base and Competitors
  5.5.2 NT 3 Growth Factor Receptor Product Category, Application and Specification
    5.5.2.1 Product A
    5.5.2.2 Product B
  5.5.3 Ignyta Inc NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.5.4 Main Business/Business Overview
5.6 Loxo Oncology Inc
  5.6.1 Company Basic Information, Manufacturing Base and Competitors
  5.6.2 NT 3 Growth Factor Receptor Product Category, Application and Specification
    5.6.2.1 Product A
    5.6.2.2 Product B
  5.6.3 Loxo Oncology Inc NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.6.4 Main Business/Business Overview
5.7 Netris Pharma SAS
  5.7.1 Company Basic Information, Manufacturing Base and Competitors
  5.7.2 NT 3 Growth Factor Receptor Product Category, Application and Specification
    5.7.2.1 Product A
    5.7.2.2 Product B
  5.7.3 Netris Pharma SAS NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.7.4 Main Business/Business Overview
5.8 Plexxikon Inc
  5.8.1 Company Basic Information, Manufacturing Base and Competitors
  5.8.2 NT 3 Growth Factor Receptor Product Category, Application and Specification
    5.8.2.1 Product A
    5.8.2.2 Product B
  5.8.3 Plexxikon Inc NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.8.4 Main Business/Business Overview

6 NT 3 GROWTH FACTOR RECEPTOR MANUFACTURING COST ANALYSIS

6.1 NT 3 Growth Factor Receptor Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of NT 3 Growth Factor Receptor

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 NT 3 Growth Factor Receptor Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of NT 3 Growth Factor Receptor Major Manufacturers in 2017
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 JAPAN NT 3 GROWTH FACTOR RECEPTOR MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

10.1 Japan NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
10.2 Japan NT 3 Growth Factor Receptor Sales (K Pcs) Forecast by Type (2018-2025)
10.3 Japan NT 3 Growth Factor Receptor Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION



The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Japan Market Size (Million USD) Status and Outlook (2013-2025)
Table NT 3 Growth Factor Receptor Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table NT 3 Growth Factor Receptor Sales (K Pcs) by Application (2017-2025)
Figure Product Picture of NT 3 Growth Factor Receptor
Table Japan NT 3 Growth Factor Receptor Sales (K Pcs) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure Japan NT 3 Growth Factor Receptor Sales Volume Market Share by Type in 2017
Figure AZD-7451 Product Picture
Figure Larotrectinib Product Picture
Figure DS-6051 Product Picture
Figure LM-22B10 Product Picture
Figure Others Product Picture
Figure Japan NT 3 Growth Factor Receptor Sales (K Pcs) Comparison by Application (2013-2025)
Figure Japan Sales Market Share (%) of NT 3 Growth Factor Receptor by Application in 2017
Figure Breast Cancer Examples
Figure Brain Cancer Examples
Figure Solid Tumor Examples
Figure Colon Cancer Examples
Figure Fibrosarcoma Examples
Figure Others Examples
Figure Japan NT 3 Growth Factor Receptor Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure Japan NT 3 Growth Factor Receptor Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Japan NT 3 Growth Factor Receptor Sales of Key Players/Manufacturers (2013-2018)
Table Japan NT 3 Growth Factor Receptor Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Japan NT 3 Growth Factor Receptor Sales Share (%) by Players/Manufacturers
Figure 2017 Japan NT 3 Growth Factor Receptor Sales Share (%) by Players/Manufacturers
Table Japan NT 3 Growth Factor Receptor Revenue by Players/Manufacturers (2013-2018)
Table Japan NT 3 Growth Factor Receptor Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Japan NT 3 Growth Factor Receptor Revenue Share (%) by Players/Manufacturers
Figure 2017 Japan NT 3 Growth Factor Receptor Revenue Share (%) by Players/Manufacturers
Table Japan Market NT 3 Growth Factor Receptor Average Price (USD/Pcs) of Key Players/Manufacturers (2013-2018)
Figure Japan Market NT 3 Growth Factor Receptor Average Price (USD/Pcs) of Key Players/Manufacturers in 2017
Figure Japan NT 3 Growth Factor Receptor Market Share of Top 3 Players/Manufacturers
Figure Japan NT 3 Growth Factor Receptor Market Share of Top 5 Players/Manufacturers
Table Japan Players/Manufacturers NT 3 Growth Factor Receptor Manufacturing Base Distribution and Sales Area
Table Japan Players/Manufacturers NT 3 Growth Factor Receptor Product Category
Table Japan NT 3 Growth Factor Receptor Sales (K Pcs) by Type (2013-2018)
Table Japan NT 3 Growth Factor Receptor Sales Share (%) by Type (2013-2018)
Figure Japan NT 3 Growth Factor Receptor Sales Share (%) by Type (2013-2018)
Figure Japan NT 3 Growth Factor Receptor Sales Market Share (%) by Type in 2017
Table Japan NT 3 Growth Factor Receptor Revenue (Million USD) and Market Share by Type (2013-2018)
Table Japan NT 3 Growth Factor Receptor Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of NT 3 Growth Factor Receptor by Type (2013-2018)
Figure Revenue Market Share of NT 3 Growth Factor Receptor by Type in 2017
Table Japan NT 3 Growth Factor Receptor Price (USD/Pcs) by Type (2013-2018)
Figure Japan NT 3 Growth Factor Receptor Sales Growth Rate (%) by Type (2013-2018)
Table Japan NT 3 Growth Factor Receptor Sales (K Pcs) by Application (2013-2018)
Table Japan NT 3 Growth Factor Receptor Sales Market Share (%) by Application (2013-2018)
Figure Japan NT 3 Growth Factor Receptor Sales Market Share (%) by Application (2013-2018)
Figure Japan NT 3 Growth Factor Receptor Sales Market Share (%) by Application in 2017
Table Japan NT 3 Growth Factor Receptor Sales Growth Rate (%) by Application (2013-2018)
Figure Japan NT 3 Growth Factor Receptor Sales Growth Rate (%) by Application (2013-2018)
Table Array BioPharma Inc NT 3 Growth Factor Receptor Basic Information List
Table Array BioPharma Inc NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Array BioPharma Inc NT 3 Growth Factor Receptor Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Array BioPharma Inc NT 3 Growth Factor Receptor Sales Market Share (%) in Japan (2013-2018)
Figure Array BioPharma Inc NT 3 Growth Factor Receptor Revenue Market Share (%) in Japan (2013-2018)
Table AstraZeneca Plc NT 3 Growth Factor Receptor Basic Information List
Table AstraZeneca Plc NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure AstraZeneca Plc NT 3 Growth Factor Receptor Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure AstraZeneca Plc NT 3 Growth Factor Receptor Sales Market Share (%) in Japan (2013-2018)
Figure AstraZeneca Plc NT 3 Growth Factor Receptor Revenue Market Share (%) in Japan (2013-2018)
Table Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Basic Information List
Table Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Sales Market Share (%) in Japan (2013-2018)
Figure Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Revenue Market Share (%) in Japan (2013-2018)
Table Handok Inc NT 3 Growth Factor Receptor Basic Information List
Table Handok Inc NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Handok Inc NT 3 Growth Factor Receptor Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Handok Inc NT 3 Growth Factor Receptor Sales Market Share (%) in Japan (2013-2018)
Figure Handok Inc NT 3 Growth Factor Receptor Revenue Market Share (%) in Japan (2013-2018)
Table Ignyta Inc NT 3 Growth Factor Receptor Basic Information List
Table Ignyta Inc NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Ignyta Inc NT 3 Growth Factor Receptor Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Ignyta Inc NT 3 Growth Factor Receptor Sales Market Share (%) in Japan (2013-2018)
Figure Ignyta Inc NT 3 Growth Factor Receptor Revenue Market Share (%) in Japan (2013-2018)
Table Loxo Oncology Inc NT 3 Growth Factor Receptor Basic Information List
Table Loxo Oncology Inc NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Loxo Oncology Inc NT 3 Growth Factor Receptor Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Loxo Oncology Inc NT 3 Growth Factor Receptor Sales Market Share (%) in Japan (2013-2018)
Figure Loxo Oncology Inc NT 3 Growth Factor Receptor Revenue Market Share (%) in Japan (2013-2018)
Table Netris Pharma SAS NT 3 Growth Factor Receptor Basic Information List
Table Netris Pharma SAS NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Netris Pharma SAS NT 3 Growth Factor Receptor Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Netris Pharma SAS NT 3 Growth Factor Receptor Sales Market Share (%) in Japan (2013-2018)
Figure Netris Pharma SAS NT 3 Growth Factor Receptor Revenue Market Share (%) in Japan (2013-2018)
Table Plexxikon Inc NT 3 Growth Factor Receptor Basic Information List
Table Plexxikon Inc NT 3 Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Plexxikon Inc NT 3 Growth Factor Receptor Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Plexxikon Inc NT 3 Growth Factor Receptor Sales Market Share (%) in Japan (2013-2018)
Figure Plexxikon Inc NT 3 Growth Factor Receptor Revenue Market Share (%) in Japan (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of NT 3 Growth Factor Receptor
Figure Manufacturing Process Analysis of NT 3 Growth Factor Receptor
Figure NT 3 Growth Factor Receptor Industrial Chain Analysis
Table Raw Materials Sources of NT 3 Growth Factor Receptor Major Players/Manufacturers in 2017
Table Major Buyers of NT 3 Growth Factor Receptor
Table Distributors/Traders List
Figure Japan NT 3 Growth Factor Receptor Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Japan NT 3 Growth Factor Receptor Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan NT 3 Growth Factor Receptor Price (USD/Pcs) Trend Forecast (2018-2025)
Table Japan NT 3 Growth Factor Receptor Sales (K Pcs) Forecast by Type (2018-2025)
Figure Japan NT 3 Growth Factor Receptor Sales (K Pcs) Forecast by Type (2018-2025)
Figure Japan NT 3 Growth Factor Receptor Sales Volume Market Share Forecast by Type in 2025
Table Japan NT 3 Growth Factor Receptor Sales (K Pcs) Forecast by Application (2018-2025)
Figure Japan NT 3 Growth Factor Receptor Sales Volume Market Share Forecast by Application (2018-2025)
Figure Japan NT 3 Growth Factor Receptor Sales Volume Market Share Forecast by Application in 2025